Search This Blog

Thursday, November 6, 2025

Alleged NJ jihadi yuppies posed with weapons, talked beheading infidels, attacking Jews: docs

 Alleged Montclair NJ jihadi yuppies said they wanted to behead infidels and become famous for ISIS-inspired terror attacks and also fantasized about executing Jews and carrying out antisemitic attacks in the multicultural New York City suburb, according to chilling new docs released by the feds.

Jimenez-Guzel took a picture of himself in front of an ISIS flag.Obtained by the NY Post

Tomas Kaan Jimenez-Guzel, 19, who lived at his parents’ million-dollar home in the wealthy New Jersey city, was arrested at Newark Airport on Wednesday as he waited to board a flight to Turkey. Authorities said he planned to travel to Syria to join ISIS, to which he had sworn allegiance, according to a 48-page criminal complaint.

The feds also released pics of Jimenez-Guzel, the son of a UN diplomat who heads a women’s business agency, posing in front of an ISIS flag and wielding a knife.

Suspect Milo Sedarat, 19, the son of a noted Iranian-American poet, meanwhile, raged about his mother having Jewish friends and said he wanted to execute “500 Jews” and make their wives and children slaves, according to federal docs.

The teen jihadist posted photos of himself referencing jihad.Obtained by the NY Post

Also arrested was alleged co-conspirator Saed Ali Mirreh, also 19, of Kent, Washington, whom feds tracked down and busted at his suburban Washington a day before he too was scheduled to fly to Turkey.

Group chats held by the teens, and other participants in the alleged conspiracy, painted a portrait of angry, violence-obsessed young men who fell deeply into jihadist indoctrination.

The yuppie jihadis posed with weapons.Obtained by the NY Post

In one video call, Mirreh said all of the plotters would have to be prepared to slice people’s throats if the group needed to make any propaganda videos. Jiminez-Guzel disagreed, and happily volunteered to do any beheadings himself, coldly saying, “I’ll do it, bro,” the complaint alleges.

In another group chat, Jimenez-Guzel mused about desiring infamy, and said he wanted the group to “do something that’s going to leave a mark in history. Something that’s gonna make them create a documentary on you on Netflix. Something that’s gonna make you have a Wikipedia page.”

He also boasted to the group chat that he would wind up being “one of the most 100 evil people in the world.”

Milo Sedarat posing with a swordObtained by the NY Post

Mirreh noted in the chat at one point that everyone in the group would have to “unalive” — meaning to kill somebody — similar to an inner-city gang initiation “to get that mentality and to get into our brain that we unalive someone and once we come, we don’t hesitate no more,” he allegedly said.

Jimenez-Guzel responded, “bro, it’ll be easy for me,” and Mirreh agreed.

A social media post shared by Jimenez-Guzel included a document in Arabic titled in English “KILL THEM SILENTLY.” The document encouraged Muslims to practice the “obligation” of jihad and “terrorize the disbelievers to avenge their Muslim brothers.”

Gazel with his mother, Meral.Facebook/Meral Guzel

The document urged followers to use knives, axes, and vehicles to attack Christians and Jews, and suggested that all that was needed was a knife, hammer, or even less to cause chaos and destruction on a large scale across Europe and America.

Both men are facing charges including conspiracy to provide material support to a foreign terrorist organization and attempted conspiracy to provide material support to a foreign terrorist organization. Jimenez-Guzel had his initial court appearance at Newark federal court on Wednesday, while Mirreh appeared before a judge in Seattle federal court.

Each count carries a maximum sentence of 20 years if convicted, along with a $250,000 fine and lifetime supervised release. 

https://nypost.com/2025/11/06/us-news/montclair-jihadi-yuppies-posed-with-weapons-ranted-about-attacking-jews-docs/

Old story worth reprising: 'Fetterman Brags That Brain Damage Made Him Abandon Progressives'

During an appearance on Real Time With Bill Maher, Senator John Fetterman credited his near-fatal stroke with making him a conservative darling, describing it as “freeing.”

“There’s a line from the first Batman, Joker, he’s like, ‘I’ve already been dead once already. It’s very liberating,’” Fetterman told Maher on Friday. “That’s not reckless, that’s just freeing. It’s just freeing in a way. And I just think after beating all of that, I just really want to be able to say the things that I have to really believe in and not be afraid of if there’s any kind of blowback.”

Following the October 7 Hamas attack, Fetterman broke from the progressives who got him elected to saber-rattle for Israel’s brutal attacks on Gaza. His stance has largely been antagonistic, trolling protesters rallying for a cease-fire by waving an Israel flag over them, laughing at military veterans getting arrested protesting for a cease-fire, and castigating the United States for abstaining from a cease-fire resolution instead of voting against it. He has described student encampment protests as “pup tents for Hamas” and spread debunked propaganda denigrating pro-Palestine demonstrations in Philadelphia.

Since adopting an aggressively pro-Israel stance, Fetterman has also backed harsher border policies—a curious stance given that he used to point to his wife’s undocumented status as a child to tout his progressive bona fides.

Fetterman frames his seismic shift as stances he’s always had, which his brain damage simply allowed him the freedom to embrace—despite constantly describing himself as a progressive through the years, seeking endorsement from the Democratic Socialists of America, and himself endorsing progressive candidates for office.

While progressives who campaigned hard for Fetterman feel betrayed by his shift, conservatives have celebrated Fetterman’s self-described brain damage–induced embrace of right-wing positions—itself a clear signal he’s garnering the wrong audience.

“It’s heartwarming to see regular people using their brain,” said one account on X (formerly Twitter) in response to a white nationalist disinformation account boosting Fetterman’s interview with Maher.

“If only there was some way we could repeat this experiment with other elected officials,” replied another user in response to a Fox News post about how Fetterman’s brain damage “freed” him.

https://www.yahoo.com/news/john-fetterman-brags-brain-damage-160640817.html

Axsome acquires epilepsy treatmnt

 Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA Î±2,3 receptor positive allosteric modulator

Deepens Axsome’s broad and innovative neuroscience portfolio with a synergistic early-stage program for epilepsy

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into an agreement to obtain exclusive global rights to AZD7325, a novel oral GABAA receptor α2,3 subtype-selective positive allosteric modulator (PAM), licensed from AstraZeneca AB (NASDAQ: AZN). AZD7325 has completed Phase 1 trials. Axsome intends to evaluate AZD7325 as a potential treatment for epilepsy and plans to begin Phase 2 trial-enabling activities in 2026.

“This transaction adds AZD7325, an earlier stage molecule with a differentiated mechanism of action, to our leading late-stage CNS portfolio,” said Herriot Tabuteau, MD, Chief Executive Officer of Axsome. “We are excited to further deepen our research pipeline in a complementary way, and to extend our clinical efforts into epilepsy, an area where there is an urgent need for innovative new treatment options for patients.”

AZD7325 has demonstrated anti-convulsant effects in preclinical seizure models. In clinical studies in over 700 patients to date, AZD7325 has demonstrated a favorable safety and tolerability profile.

Axsome will receive worldwide commercial, development, and manufacturing rights to AZD7325. The transaction was effectuated through Axsome’s acquisition of a 100% equity interest in Baergic Bio, Inc., a subsidiary of Avenue Therapeutics, Inc. (OTC: ATXI), and concurrent amendment to the License Agreement between Baergic Bio and AstraZeneca. Under the terms of the Baergic Bio Share Purchase Agreement, Baergic Bio shareholders will receive a $0.3 million upfront payment and are eligible to receive development and regulatory milestone payments of $2.5 million for the first indication and $1.5 million for each indication thereafter, up to $79 million in potential sales-based milestones, and a tiered mid-to-high single-digit royalty on potential global net sales of AZD7325. Under the terms of the License Amendment, AstraZeneca will receive a cash upfront payment in the single digit millions and is eligible to receive development and regulatory milestone payments for each indication, sales-based milestones, and a tiered mid-to-high single-digit royalty on potential global net sales of AZD7325.

https://finviz.com/news/220612/axsome-therapeutics-acquires-subtype-selective-gaba-a-receptor-positive-allosteric-modulator-azd7325-for-the-treatment-of-epilepsy

Genelux Q3 and update



Genelux (NASDAQ: GNLX) reported third quarter 2025 results and clinical updates on Nov 5, 2025. The company held $21.0 million in cash, cash equivalents, short-term investments and restricted cash as of Sept 30, 2025, which management expects will fund operations into the third quarter of 2026. Topline data from the OnPrime Phase 3 ovarian cancer registrational trial is now anticipated in the second half of 2026. Additional interim data from two systemically delivered Olvi-Vec lung cancer trials are expected in Q4 2025 and through 2026. Q3 2025 net loss was $8.0 million (loss per share $0.21); R&D was $4.7 million and G&A was $3.5 million.

Key program notes: OnPrime remains enrolling in the U.S.; the Independent Data Monitoring Committee has recommended continuation; company believes positive PFS without OS decrement could support traditional FDA approval based on a Type D meeting.

Microsoft to Pursue Superintelligence After OpenAI Deal

 


Microsoft Corp. is pursuing a more powerful form of AI called “superintelligence” it hopes will be capable of making advances in areas like medicine and materials science.

Mustafa Suleyman, chief of the Microsoft AI group, will lead what the company is calling the MAI Superintelligence Team that will target hypothetical milestones that are even more ambitious than artificial general intelligence. That’s the often ambiguous term that outfits like OpenAI use to describe systems capable of demonstrating human-level performance. Previously Microsoft had agreed not to pursue AGI as part of its partnership with OpenAI.

https://www.bloomberg.com/news/articles/2025-11-06/microsoft-aims-at-superintelligence-after-revising-openai-ties

Planet Fitness Adds New Clubs, Sweetens Profit Outlook

 Planet Fitness Inc. (NYSE:PLNT) shares rose Thursday after the company posted its third-quarter results, which topped street estimates.

The company reported adjusted earnings per share of 80 cents, up from 64 cents a year ago, topping analysts’ estimates of 74 cents.

Total Revenue rose 13.0% to $330.35 million, ahead of Wall Street expectations of $323.43 million.

System-wide sales rose to $1.3 billion, up from $1.2 billion a year earlier, while system-wide same club sales increased 6.9%.

Adjusted EBITDA climbed $17.7 million to $140.76 million from the prior year period.

The company ended the quarter with $385.41 million in cash, cash equivalents and restricted cash.

Planet Fitness stated that it repurchased approximately $100 million of its shares during the quarter.

Planet Fitness opened 35 new clubs system-wide during the quarter, including 29 franchise-owned and six corporate-owned locations, bringing its total footprint to 2,795 clubs as of September 30, 2025.

Segment Performance

Franchise segment revenue increased 11.0% to $113.68 million, while Corporate-owned clubs segment revenue increased 7.6% to $137.83 million from the prior year period. Equipment segment revenue increased 27.8% to $78.84 million compared to the prior year period.

Franchise segment adjusted EBITDA rose 13.2% to $82.37 million, while corporate-owned clubs posted a 6.6% increase to $53.74 million. The equipment segment adjusted EBITDA jumped 28.3% to $23.72 million.

Outlook

The company said it continues to believe its tariff-mitigation plans and current tariff levels limit exposure, and its guidance does not assume any impact from potential tariff changes beyond existing regulations.

For the full-year 2025, management maintained expectations for approximately 130 to 140 new equipment placements at franchise-owned locations and 160 to 170 new system-wide club openings.

The company also raised several growth targets over 2024 results, now forecasting same-club sales growth of about 6.5% (up from 6.0%), revenue growth of roughly 11% (up from 10%), adjusted EBITDA growth of about 12% (up from 10%), and adjusted net income growth of 13% to 14% (up from 8% to 9%).

Adjusted diluted EPS is now expected to increase 16% to 17% (up from 11% to 12%), based on an estimated 84.2 million adjusted diluted weighted-average shares outstanding, reflecting repurchases completed through the third quarter of 2025.

Planet Fitness raised its fiscal 2025 adjusted EPS outlook to $3.00–$3.03 from $2.87–$2.90, topping the $2.96 consensus, while reducing its sales guidance to $1.312 billion from $1.430 billion, roughly in line with the $1.305 billion estimate.

The company continues to expect net interest expense of approximately $86 million for 2025, capital expenditures to rise about 20% driven by expansion of corporate-owned clubs, and depreciation and amortization of roughly $155 million.

CEO Commentary

Colleen Keating, Chief Executive Officer, stated, “We are making significant progress in executing on our long-term strategy, as highlighted by our strong financial performance during the quarter, which enabled us to raise certain growth targets for our 2025 outlook.”

https://www.benzinga.com/markets/earnings/25/11/48684905/planet-fitness-adds-new-clubs-sweetens-profit-outlook

Steris (STE) stock surged 8.6% today after reporting strong Q3 2025 results that beat expectations

 raising its full-year earnings outlook.

https://finviz.com/quote.ashx?t=STE&p=d